室管膜下瘤是由脑室下区谱系标志物界定的低级别异质性胶质肿瘤
本研究回顾性分析了1998至2016年间在本机构病理确诊的31例室管膜下瘤患者,其中7例为尸检发现的無症状病变,24例有症状者接受手术。免疫组化显示肿瘤表达GFAP及Olig2、NHERF1、Sox2、CD44等标志物,Ki67增殖指数普遍较低(许多肿瘤<1%)。结论认为室管膜下瘤可能起源于脑室下区的多能胶质祖细胞,确诊需手术取样,尽管临床过程似良性,但影像学无法确诊及存在恶性病变可能支持早期安全最大程度切除。
要点
- 31例病理确诊室管膜下瘤中,侧脑室15例(48%)、第四脑室11例(35%)、脊髓5例(17%)。
- 有症状颅内病变最常见表现为头痛及平衡和步态异常。
- 免疫组化显示弥漫GFAP阳性,混有可变表达Olig2、NHERF1、Sox2、CD44的细胞群,Ki67增殖指数普遍低(许多肿瘤<1%)。
核心结论
- 室管膜下瘤显示表达胶质谱系标志物及推定干细胞标志物的混合细胞群,提示这些肿瘤可能起源于脑室下区的多能胶质祖细胞。
- 确诊需要手术取样;尽管临床过程似良性,但影像学无法诊断这些病变及存在替代恶性病变的可能性支持早期安全最大程度切除的低阈值。
研究设计与样本
- 回顾性识别1998年至2016年间在本机构就诊的所有病理确诊室管膜下瘤患者。
- 回顾性审查所有接受手术切除患者的临床、影像、组织学及手术结局数据。
- 进行细胞谱系标志物的免疫组化分析。
主要发现
- 共识别31例病理确诊室管膜下瘤患者,其中7例無症状病变在尸检时发现,24例有症状病例接受手术治疗。
- 肿瘤位置:侧脑室15例(48%),第四脑室11例(35%),脊髓5例(17%)。
- 有症状颅内病变最常见表现为头痛及平衡和步态异常。
- 室管膜下瘤无提供明确术前诊断的鉴别性影像学特征。
- 末次随访时,无接受手术治疗的患者出现复发。
临床怎么用
- 作者认为,尽管室管膜下瘤的临床过程似良性,但影像学无法诊断这些病变及存在替代恶性病变的可能性支持早期安全最大程度切除的低阈值。
- 确诊需要手术取样。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Subependymomas are infrequent, low-grade gliomas associated with the ventricular system and the spinal cord. Little is known about the origin and natural history of these slow-growing lesions. METHODS: We identified all patients with pathologically proven subependymomas presenting to our institution between 1998 and 2016. We retrospectively reviewed clinical, radiographic, histologic, and surgical outcomes data in all patients who underwent surgical resection. Immunohistochemical analyses for cell lineage markers were performed. RESULTS: A total of 31 patients with pathologically proven subependymomas were identified. Of these, 7 asymptomatic lesions were discovered at autopsy and 24 symptomatic cases were treated surgically. There were 15 (48%) lateral ventricle tumors, 11 (35%) fourth ventricular tumors, and 5 (17%) spinal tumors. Symptomatic intracranial lesions most commonly presented with headaches and balance and gait abnormalities. Subependymomas had no distinguishing radiographic features that provided definitive preoperative diagnosis. At last follow-up, no patient treated surgically experienced recurrence. Immunohistochemical analyses demonstrated a diffusely GFAP-positive glial neoplasm with mixed populations of cells that were variably positive for Olig2, NHERF1, Sox2, and CD44. The Ki67 proliferation index was generally low (<1% in many of the tumors). CONCLUSIONS: Subependymomas demonstrate mixed populations of cells expressing glial lineage markers as well as putative stem cell markers, suggesting these tumors may arise from multipotent glial progenitors that reside in the subventricular zone. Definitive diagnosis requires surgical sampling. Although the clinical course of subependymomas appears benign, the inability to radiographically diagnose these lesions, and the possibility of an alternative malignant lesion support a low threshold for early and safe maximal resection.
引用
- D'Amico RS, Praver M, Zanazzi GJ, et al. Subependymomas Are Low-Grade Heterogeneous Glial Neoplasms Defined by Subventricular Zone Lineage Markers. World Neurosurg. 2017. PMID: 28804038. doi:10.1016/j.wneu.2017.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。